Area of research
Dermatology · Oncology
Research interest
Research interests include Medicine, HRAS, Biology, Cancer research, KRAS, and Nevus.
Laser and Photodynamic Therapy
Laser and Photodynamic Therapy
Phototherapy‐induced elevation of serum level of melanoma inhibitory activity
Laser, hochenergetische Blitzlampen und photodynamische Therapie
Laser, hochenergetische Blitzlampen und photodynamische Therapie
Effects of Cold Atmospheric Plasma (CAP) on ß-Defensins, Inflammatory Cytokines, and Apoptosis-Related Molecules in Keratinocytes In Vitro and In Vivo
BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma
Fractional carbon dioxide laser resurfacing of rhytides and photoaged skin – A prospective clinical study on patient expectation and satisfaction
Therapy of Vascular Lesions in the Head and Neck Area by Means of Argon, Nd:YAG, CO2 and Flashlamp-Pumped Pulsed Dye Lasers
Luminescent Dual Sensors Reveal Extracellular pH-Gradients and Hypoxia on Chronic Wounds That Disrupt Epidermal Repair
Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum
<scp>CHILD</scp> syndrome with mild skin lesions: histopathologic clues for the diagnosis
Phacomatosis Pigmentokeratotica Is Caused by a Postzygotic HRAS Mutation in a Multipotent Progenitor Cell
Low Incidence of Oncogenic EGFR, HRAS, and KRAS Mutations in Seborrheic Keratosis
Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome
Keratinocytic epidermal nevi are associated with mosaic <i>RAS</i> mutations
Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma
A <scp>s</scp>prayable luminescent pH sensor and its use for wound imaging <i>in vivo</i>
Impact of Age and Body Site on Adult Female Skin Surface pH
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: An open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study